SCHEMBL23155245

SCHEMBL23155245

c1ccc2c(c1)-c1cccc3c1-c1cc(N(c4ccc5ccccc5c4)c4ccc5oc6ccccc6c5c4)ccc1-c1cccc-3c1-2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.36
▸ KDM4E B2RXH2 6/20 0.36
▸ MAPT P10636 5/20 0.36
▸ HPGD P15428 5/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ AHR P35869 2/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ DNMT1 P26358 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ GLA P06280 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155244 0.93 AHR (0.36) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155370 0.89 MAPT (0.39) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155167 0.87 MAPT (0.35) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155249 0.86 L3MBTL1 (0.32) ALDH1A1HPGDDNMT1TSHRHSD17B10
SCHEMBL17737641 0.85 KDM4E (0.47) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155330 0.85 NPC1 (0.36) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155390 0.85 ALOX5 (0.39) NPC1RAB9AAHRALOX5DNMT1
SCHEMBL25580649 0.85 ALDH1A1 (0.34) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL23155208 0.84 DNMT1 (0.36) ALDH1A1HPGDDNMT1CYP1A2TSHR
SCHEMBL25580930 0.84 ALDH1A1 (0.34) ALDH1A1KDM4EMAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 ALDH1A1 1348/4885KDM4E 2359/4885MAPT 4116/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 ALDH1A1 1348/4885KDM4E 2359/4885MAPT 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback